Catégories
English-site MDR-Register

(en)-Register of MDR and RR tuberculosis

One of the missions of the NRC for mycobacteria is the surveillance and help in the management of multidrug-resistant tuberculosis. To help fulfilling this objective, the NRC for mycobacteria has implemented a register for MDR-TB and RR-TB cases

This electronic register can be accessed physicians and clinical pathologists in charge of the patients as well as NRC and TB consilium members providing help in the management of the cases. Access is granted after NRC validation and is personal and password protected.

More details can be found on the French page of the register.

Catégories
English-site

(en)-NRC activities

Page top

Page top

  • Research

Catégories
Documents English-site

Documents, Rapports et Publications

Docs, reports and publications

Catégories
Documents English-site Tout le CNR-MyRMA

Publications du CNR-MyRMA

Publications of the NRC

Publications 2023

Cliquer ici pour toutes les publications du CNR-MyRMA en 2023


























“Clinical Implications of Molecular Drug Resistance Testing for Mycobacterium Tuberculosis: A 2023 TBnet/RESIST-TB Consensus Statement” by José Domínguez et al. The Lancet Infectious Diseases, February 28, 2023. https://doi.org/10.1016/S1473-3099(22)00875-1.

Publications 2022

Cliquer ici pour toutes les publications du CNR-MyRMA en 2022 – extrait ci-dessous


























“Lipophilic Quinolone Derivatives: Synthesis and in Vitro Antibacterial Evaluation” by Elodie Sadowski et al. Bioorganic & Medicinal Chemistry Letters. 55 (January 1, 2022). https://doi.org/10.1016/j.bmcl.2021.128450.

Publications 2021

Cliquer ici pour toutes les publications du CNR-MyRMA en 2021


























“A Comprehensive Evaluation of GeneLEAD VIII DNA Platform Combined to Deeplex Myc-TB® Assay to Detect in 8 Days Drug Resistance to 13 Antituberculous Drugs and Transmission of Mycobacterium Tuberculosis Complex Directly From Clinical Samples” by Isabelle Bonnet et al. Frontiers in Cellular and Infection Microbiology. 11 (October 29, 2021). https://doi.org/10.3389/fcimb.2021.707244.

Publications 2020

Cliquer ici pour toutes les publications du CNR-MyRMA en 2020


























“Rifampicin and Clarithromycin (Extended Release) versus Rifampicin and Streptomycin for Limited Buruli Ulcer Lesions: A Randomised, Open-Label, Non-Inferiority Phase 3 Trial” by Richard O Phillips et al. The Lancet. 395, no. 10232 (April 18, 2020). https://doi.org/10.1016/S0140-6736(20)30047-7.

Publications 2019

Cliquer ici pour toutes les publications du CNR-MyRMA en 2019


























“Overall Structures of Mycobacterium Tuberculosis DNA Gyrase Reveal the Role of a Corynebacteriales GyrB-Specific Insert in ATPase Activity” by Stéphanie Petrella et al. Structure. 27, no. 4 (avril 2019). https://doi.org/10.1016/j.str.2019.01.004.

Publications 2018

Cliquer ici pour toutes les publications du CNR-MyRMA en 2018


























“Antimicrobial Resistance in Leprosy: Results of the First Prospective Open Survey Conducted by a WHO Surveillance Network for the Period 2009–15” by E. Cambau et al. Clinical Microbiology and Infection. 24, no. 12 (December 1, 2018). https://doi.org/10.1016/j.cmi.2018.02.022.

Publications 2017

Cliquer ici pour toutes les publications du CNR-MyRMA en 2017


























“Are Moxifloxacin and Levofloxacin Equally Effective to Treat XDR Tuberculosis?” by Thomas Maitre et al. Journal of Antimicrobial Chemotherapy. 72, no. 8 (August 1, 2017). https://doi.org/10.1093/jac/dkx150.

Publications 2016

Cliquer ici pour toutes les publications du CNR-MyRMA en 2016


























“In Vivo Mycobacterium Tuberculosis Fluoroquinolone Resistance Emergence: A Complex Phenomenon Poorly Detected by Current Diagnostic Tests” by Christine Bernard et al. The Journal of Antimicrobial Chemotherapy, September 7, 2016. https://doi.org/10.1093/jac/dkw344.

Publications 2015

Cliquer ici pour toutes les publications du CNR-MyRMA en 2015


























“Compassionate Use of Bedaquiline for the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Interim Analysis of a French Cohort” by Lorenzo Guglielmetti et al. Clinical Infectious Diseases. 60, no. 2 (January 15, 2015). https://doi.org/10.1093/cid/ciu786.

Publications 2014

Cliquer ici pour toutes les publications du CNR-MyRMA en 2014


























“Comparison of a Semiautomated Commercial Repetitive-Sequence-Based PCR Method with Spoligotyping, 24-Locus Mycobacterial Interspersed Repetitive-Unit–Variable-Number Tandem-Repeat Typing, and Restriction Fragment Length Polymorphism-Based Analysis of IS6110 for Mycobacterium Tuberculosis Typing” by F. Brossier et al. Journal of Clinical Microbiology. 52, no. 11 (November 1, 2014). https://doi.org/10.1128/JCM.02226-14.

Publications 2013

Cliquer ici pour toutes les publications du CNR-MyRMA en 2013


























“Resistance of M. Leprae to Quinolones: A Question of Relativity?” by Nicolas Veziris et al. PLoS Negl Trop Dis. 7, no. 11 (November 14, 2013). https://doi.org/10.1371/journal.pntd.0002559.

Publications 2012

Cliquer ici pour toutes les publications du CNR-MyRMA en 2012 / click here


























“Extending the Definition of the GyrB Quinolone Resistance-Determining Region in Mycobacterium Tuberculosis DNA Gyrase for Assessing Fluoroquinolone Resistance in M. Tuberculosis” by Alix Pantel et al. Antimicrobial Agents and Chemotherapy. 56, no. 4 (April 2012). https://doi.org/10.1128/AAC.06272-11.

Publications 2011

Cliquer ici pour toutes les publications du CNR-MyRMA en 2011 / click here


























“Crystal Structure of the Pyrazinamidase of Mycobacterium Tuberculosis : Insights into Natural and Acquired Resistance to Pyrazinamide” by Stéphanie Petrella et al. PLOS ONE. 6, no. 1 (January 24, 2011). https://doi.org/10.1371/journal.pone.0015785.

Publications 2010

Cliquer ici pour toutes les publications du CNR-MyRMA en 2010 / click here


























“Detection by GenoType MTBDRsl Test of Complex Mechanisms of Resistance to Second-Line Drugs and Ethambutol in Multidrug-Resistant Mycobacterium Tuberculosis Complex Isolates” by Florence Brossier et al. Journal of Clinical Microbiology. 48, no. 5 (May 1, 2010). https://doi.org/10.1128/JCM.01947-09.